<div id="readability-page-1"><div><h2>Why InTest’s latest earnings matter for investors</h2> <p>InTest (INTT) is back in focus after first quarter results showed sales of US$33.89 million and net income of US$0.789 million, alongside new second quarter guidance and a higher full year revenue outlook.</p> <p>See our latest analysis for InTest.</p> <p>The earnings beat and raised guidance have come alongside strong momentum in the stock, with a 90 day share price return of 80% and a 1 year total shareholder return of 212.4%, even though the 3 year total shareholder return is slightly negative.</p> <p>If the recent move in InTest has you considering where else growth stories could emerge, it may be worth scanning 41 AI infrastructure stocks</p> <p>With InTest now profitable again, a higher full year revenue outlook, and the stock trading close to its analyst price target, investors may ask whether there is still value on the table or if the market is already pricing in future growth.</p> <h2>Most Popular Narrative: 7% Overvalued</h2> <p>Analysts following InTest currently see fair value at about $17.67 per share, which sits below the last close of $18.90, and that gap is driven by specific growth and margin assumptions rather than short term trading moves.</p> <blockquote> <p><em>Diversification beyond semiconductors into defense, automotive/EV, life sciences, and safety/security markets is yielding increasing orders and reduced cyclicality, enhancing revenue resilience and opening new, higher-margin growth vectors.</em></p> </blockquote> <p><em>Read the complete narrative.</em></p> <p>Want to see what kind of revenue mix and margin profile has to show up for that fair value to stack up? The narrative leans on stronger earnings growth, firmer profitability, and a richer future earnings multiple than the stock has carried before, all tied together using a single discount rate that keeps every assumption on a tight leash.</p> <p><strong>Result: Fair Value of $17.67 (OVERVALUED)</strong></p> <p>Have a read of the narrative in full and understand what's behind the forecasts.</p> <p>However, the narrative still hinges on a recovery in weaker semiconductor and automotive markets, as well as on smooth execution at the new Malaysia facility, where delays or underutilization could pressure growth and margins.</p> <p>Find out about the key risks to this InTest narrative.</p> <h2>Another view: what the sales multiple is saying</h2> <p>The narrative-based fair value of $17.67 suggests InTest is about 7% overvalued, yet the stock trades on a P/S of 1.9x, compared with 2.7x for its fair ratio, 2.6x for peers and 8.9x for the wider US Semiconductor group. That gap points to valuation risk on the growth story, but also potential upside if sentiment shifts closer to those benchmarks. Which side of that trade-off do you think matters more for your own thesis?</p> <p>See what the numbers say about this price — find out in our valuation breakdown.</p> <figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b45dc88f-9af3-445a-88e0-ac80ee80f9d1/chart/ps-multiple-vs-industry/query-ZGF0ZT0yMDI2LTA1LTE1?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b45dc88f-9af3-445a-88e0-ac80ee80f9d1/chart/ps-multiple-vs-industry/query-ZGF0ZT0yMDI2LTA1LTE1"/><figcaption>NYSEAM:INTT P/S Ratio as at May 2026</figcaption></figure><h2>Next Steps</h2> <p>With the stock’s strong run and mixed signals on valuation, sentiment is clearly divided, so now is a good time to look at the numbers yourself and decide what really matters. To weigh the upside against the concerns in one place, review the 3 key rewards and 2 important warning signs</p> <h2>Looking for more investment ideas?</h2> <p>If InTest is on your radar, this is a good time to widen your search and line up a few more stocks that might fit your goals.</p> <ul> <li> Target quality at a discount by scanning 47 high quality undervalued stocks. These combine solid fundamentals with prices that may not fully reflect their underlying strength.   </li> <li> Prioritise resilience and sleep-better-at-night holdings by reviewing the 67 resilient stocks with low risk scores, which score well on stability and downside protection.   </li> <li> Expand your watchlist with under-the-radar businesses using the screener containing 22 high quality undiscovered gems before attention and liquidity potentially move elsewhere.   </li> </ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data         and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your         financial situation. We aim to bring you long-term focused analysis driven by fundamental data.         Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.         Simply Wall St has no position in any stocks mentioned.</em></p><div><h3><strong>New: </strong>AI Stock Screener &amp; Alerts</h3><p>Our new AI Stock Screener scans the market every day to uncover opportunities.</p><div><p>• Dividend Powerhouses (3%+ Yield)<br/>• Undervalued Small Caps with Insider Buying<br/>• High growth Tech and AI Companies</p><p>Or build your own from over 50 metrics.</p></div><p>Explore Now for Free</p></div></div></div>

INTT

<p>InTest (INTT) reported Q1 earnings of $33.89 million in sales and $0.789 million in net income, raising its revenue guidance for the year. Despite a strong stock performance, analysts consider the stock about 7% overvalued with a fair value of $17.67 per share. The company is diversifying into various markets, enhancing revenue resilience. Investors are advised to weigh the potential upside against valuation risks and consider broader investment opportunities.</p>

A Look At InTest (INTT) Valuation After Earnings Beat And Raised Revenue Guidance